Consistent with our findings, one recent study using transgenic Drosophila as a PD model demonstrated that Lrrk2 containing pathogenic mutations inhibits axonal transport, causing locomotor deficits in vivo [38]. The gene discussed is LRRK2; the disease is Parkinson disease.